以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 通用环球医疗集团有限公司（原名：环球医疗金融与技术咨询服务有限公司）是一家从事医疗健康业务 的中国公司。该公司主要通过两个分部运营。金融业务分部主要包括直接融资租赁、售后回租赁、保 理、经营租赁和咨询服务。医疗健康业务主要包括医疗健康服务、医院运营管理和医疗设备进出口贸易 和国内贸易、设备全周期管理和医疗数字科技服务。该公司主要在中国境内开展业务。 证券之星消息，2月23日南向资金增持171.2万股环球医疗（02666.HK）。近5个交易日中，获南向资金 增持的有4天，累计净增持479.7万股。近20个交易日中，获南向资金增持的有16天，累计净增持1416.65 万股。截至目前，南向资金持有环球医疗（02666.HK）4.56亿股，占公司已发行普通股的22.64%。 ...

Group 1 - Southbound funds increased their holdings in Universal Medical (02666.HK) by 1.3815 million shares on February 13 [1] - In the last 5 trading days, there were 4 days of net increases in holdings, totaling 4.2625 million shares [1] - Over the past 20 trading days, there were 14 days of net increases, amounting to 10.3545 million shares [1] - Currently, southbound funds hold 455 million shares of Universal Medical, representing 22.51% of the company's total issued ordinary shares [1] Group 2 - Universal Medical Group Co., Ltd. (formerly known as Universal Medical Financial and Technical Consulting Services Co., Ltd.) is a Chinese company engaged in the healthcare business [2] - The company operates mainly through two segments: financial services and healthcare services [2] - The financial services segment includes direct financing leasing, sale-leaseback, insurance, operating leasing, and consulting services [2] - The healthcare services segment encompasses healthcare services, hospital operation management, medical equipment import and export trade, domestic trade, full-cycle equipment management, and medical digital technology services [2] - The company primarily conducts its business within mainland China [2]

通用环球医疗集团有限公司（原名：环球医疗金融与技术咨询服务有限公司）是一家从事医疗健康业务 的中国公司。该公司主要通过两个分部运营。金融业务分部主要包括直接融资租赁、售后回租赁、保 理、经营租赁和咨询服务。医疗健康业务主要包括医疗健康服务、医院运营管理和医疗设备进出口贸易 和国内贸易、设备全周期管理和医疗数字科技服务。该公司主要在中国境内开展业务。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，2月12日南向资金增持92.95万股环球医疗（02666.HK）。近5个交易日中，获南向资金 增持的有4天，累计净增持347.65万股。近20个交易日中，获南向资金增持的有13天，累计净增持643.45 万股。截至目前，南向资金持有环球医疗（02666.HK）4.52亿股，占公司已发行普通股的22.45%。 | 交易日 | 持股总数(股) | 持股变动(股) | 变动幅度 | | --- | --- | --- | --- | | 2026-02-12 | 4.52亿 | 92.95万 | 0.21% | | 2026-02- ...

证券之星消息，2月11日南向资金减持18.65万股环球医疗（02666.HK）。近5个交易日中，获南向资金 增持的有4天，累计净增持329.45万股。近20个交易日中，获南向资金增持的有12天，累计净增持488.95 万股。截至目前，南向资金持有环球医疗（02666.HK）4.51亿股，占公司已发行普通股的22.4%。 通用环球医疗集团有限公司（原名：环球医疗金融与技术咨询服务有限公司）是一家从事医疗健康业务 的中国公司。该公司主要通过两个分部运营。金融业务分部主要包括直接融资租赁、售后回租赁、保 理、经营租赁和咨询服务。医疗健康业务主要包括医疗健康服务、医院运营管理和医疗设备进出口贸易 和国内贸易、设备全周期管理和医疗数字科技服务。该公司主要在中国境内开展业务。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 通用环球医疗集团有限公司（原名：环球医疗金融与技术咨询服务有限公司）是一家从事医疗健康业务 的中国公司。该公司主要通过两个分部运营。金融业务分部主要包括直接融资租赁、售后回租赁、保 理、经营租赁和咨询服务。医疗健康业务主要包括医疗健康服务、医院运营管理和医疗设备进出口贸易 和国内贸易、设备全周期管理和医疗数字科技服务。该公司主要在中国境内开展业务。 证券之星消息，2月9日南向资金增持100.2万股环球医疗（02666.HK）。近5个交易日中，获南向资金增 持的有5天，累计净增持632.65万股。近20个交易日中，获南向资金增持的有11天，累计净增持272.35万 股。截至目前，南向资金持有环球医疗（02666.HK）4.5亿股，占公司已发行普通股的22.35%。 ...

证券之星消息，2月5日南向资金增持74.75万股环球医疗（02666.HK）。近5个交易日中，获南向资金增 持的有5天，累计净增持681.25万股。近20个交易日中，获南向资金增持的有10天，累计净增持42.4万 股。截至目前，南向资金持有环球医疗（02666.HK）4.49亿股，占公司已发行普通股的22.27%。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 通用环球医疗集团有限公司（原名：环球医疗金融与技术咨询服务有限公司）是一家从事医疗健康业务 的中国公司。该公司主要通过两个分部运营。金融业务分部主要包括直接融资租赁、售后回租赁、保 理、经营租赁和咨询服务。医疗健康业务主要包括医疗健康服务、医院运营管理和医疗设备进出口贸易 和国内贸易、设备全周期管理和医疗数字科技服务。该公司主要在中国境内开展业务。 ...

通用环球医疗集团有限公司（原名：环球医疗金融与技术咨询服务有限公司）是一家从事医疗健康业务 的中国公司。该公司主要通过两个分部运营。金融业务分部主要包括直接融资租赁、售后回租赁、保 理、经营租赁和咨询服务。医疗健康业务主要包括医疗健康服务、医院运营管理和医疗设备进出口贸易 和国内贸易、设备全周期管理和医疗数字科技服务。该公司主要在中国境内开展业务。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，2月4日南向资金增持164.5万股环球医疗（02666.HK）。近5个交易日中，获南向资金增 持的有5天，累计净增持611.4万股。近20个交易日中，获南向资金减持的有11天，累计净减持584.35万 股。截至目前，南向资金持有环球医疗（02666.HK）4.48亿股，占公司已发行普通股的22.23%。 | 交易日 | 持股总数 (股) | 持股变动(股) | 变动幅度 | | --- | --- | --- | --- | | 2026-02-04 | 4.48亿 | 164.50万 | 0.37% | | 2026-02- ...

Core Insights - The company reported a total profit increase of 10.9% year-on-year, with a reduction in financing costs by 40 basis points and a labor cost reduction rate exceeding 6% [1] Group 1: Reform and Governance - Deepening state-owned enterprise reform is the main theme of the company's annual work, with 147 specific reform tasks nearly completed by year-end [2] - The company implemented a manager tenure system and contractual management, achieving a 100% signing rate, which clarified responsibilities and incentives [2] - Governance reforms included the cancellation of supervisory boards in over 30 subsidiaries, strengthening board responsibilities and modernizing corporate governance structures [2] Group 2: Financial and Industrial Synergy - The financial investment sector serves as a profit stabilizer, with the company completing the integration of 7 financial equity and asset transfers this year [3] - The company has completed 38 direct equity investment projects, with a total fund subscription scale exceeding 25 billion yuan [3] - The company is actively involved in the investment of local quality enterprises, with successful listings on capital markets and the establishment of specialized funds for high-end manufacturing [3] Group 3: Party Building and Community Engagement - The company has been recognized as a "National Civilized Unit" and received the Jiangsu Province May Day Labor Award, reflecting the integration of party building with business practices [4] - Party member volunteer teams played a crucial role in non-core enterprise cleanup and land listing tasks, with over 150 volunteers and 1,950 individuals receiving specialized training [4] - The company aims to continue its reform journey towards 2026, contributing significantly to high-quality development in Zhenjiang [4]

Group 1 - The core viewpoint of the article highlights that southbound funds have increased their holdings in Universal Medical (02666.HK) by 2.409 million shares on December 30, with a total net increase of 5.646 million shares over the past five trading days [1] - Over the last 20 trading days, there have been 14 days of net increases in holdings by southbound funds, totaling 13.834 million shares [1] - As of now, southbound funds hold 460 million shares of Universal Medical, accounting for 22.81% of the company's total issued ordinary shares [1] Group 2 - Universal Medical Group Limited, formerly known as Universal Medical Financial and Technical Consulting Services Limited, is a Chinese company engaged in the healthcare business [1] - The company operates mainly through two segments: the financial services segment, which includes direct financing leasing, sale-leaseback, insurance, operating leasing, and consulting services; and the healthcare segment, which encompasses healthcare services, hospital operation management, medical equipment import and export trade, domestic trade, full-cycle equipment management, and medical digital technology services [1] - The company's operations are primarily conducted within mainland China [1]

Group 1 - The core point of the article highlights that southbound funds reduced their holdings in Universal Medical (02666.HK) by 114,500 shares on December 22, while there were two days of net increases in the past five trading days, totaling 1,344,500 shares [1] - Over the last 20 trading days, Universal Medical experienced net increases in holdings for 12 days, with a cumulative net increase of 9,284,000 shares [1] - As of now, southbound funds hold 456 million shares of Universal Medical, accounting for 22.62% of the company's total issued ordinary shares [1] Group 2 - Universal Medical Group Limited, formerly known as Universal Medical Financial and Technical Consulting Services Limited, operates in the healthcare sector in China [1] - The company primarily operates through two segments: the financial services segment, which includes direct financing leasing, sale-leaseback, insurance, operating leasing, and consulting services; and the healthcare segment, which encompasses healthcare services, hospital operation management, medical equipment import and export trade, domestic trade, full-cycle management of equipment, and medical digital technology services [1] - The company's operations are mainly conducted within mainland China [1]